Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 280C (ZNF280C) is a C2H2-type zinc finger transcription factor involved in epigenetic regulation and DNA damage response. It binds both transcriptionally active and repressive chromatin, often coinciding with CCCTC-binding factor (CTCF) and the cohesin complex. ZNF280C is essential for maintaining trimethylation of histone H3 at lysine 27 (H3K27me3) at specific genomic loci, particularly via recruitment of the epigenetic repressor SMCHD1. It is functionally important in repressing tumor suppressor genes in colorectal cancer and is associated with worse prognosis when overexpressed. Additionally, ZNF280C helps suppress homologous recombination during the DNA damage response, further linking it to genome stability[1][2][3].
Not established for drugs, but mechanistic role involves recruiting SMCHD1 to maintain H3K27me3 and antagonism of CTCF/cohesin-mediated chromatin interactions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 280C (ZNF280C).